(INNS)
RULONILIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD1, PD-1, CD279)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-448) [VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV5-9-2*01 (95.9%) -(IGHD) - IGHJ4*01 (83.3%) S123>L (113)/HOMO SAPIENS IGHV3-23*04 (82.7%) -(IGHD) -IGHJ3*01 (90.9%) M123>L (113), CDR-IMGT [8.8.11] (26-33.51-58.97- 107)) (1-118) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1, G1V29 CH2 A84.4, G1V42 CH2 Q14, CH3 L107 (CH1 R120>K (215) (119-216), HINGE 1-15 (217-231), CH2 T14>Q (251), N84.4>A (298) (232-341), CH3 E12 (357), M14 (359), M107>L (429) (342-446), CHS (447-448)) (119-448)], (221- 218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218')...; PROPOSED INN: LIST 125, RECOMMENDED INN: LIST 87(WHO)
RULONILIMABUM(INN)